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Products  of the  H-2K  and  H-2D  genes  of the  mouse  major  histocompatibility 
complex are associated with fl2-microglobulin and are presented on the cell surface. 
Allelic products of each of these loci are codominantly expressed on somatic cells of 
heterozygotes and on somatic cell hybrids between cells of differing H-2 haplotypes 
(1).  Embryonal  carcinoma  cells  (ECC), 1 the  stem  cells  of teratocarcinoma,  and 
cleavage stage embryos do not express the H°2K and  -2D  gene products although 
they do express these products at a  later stage of development or differentiation (2). 
Two previous investigations of H-2 gene expression on teratocarcinoma somatic cell 
hybrids have been reported. Miller and Ruddle (3), with H-2 typing sera, found that 
the H-2K  k products were strongly, and the H-2K  b only weakly, expressed on the cell 
surface of  somatic cell hybrids between the teratocarcinoma cell line PCC4 azaguanine 
(aza)  1 and C3H thymocytes. Andrews and Goodfellow (4), with an identical fusion 
system, found that their hybrid cells also expressed H-2K  k antigens, but not the H- 
2D  b allelic products. These hybrids resembled ECC phenotypically, but unlike ECC, 
they  expressed  the  H-2  antigens  of the  differentiated parent.  They hypothesized, 
therefore, that H-2 gene expression in these hybrids was under cis control and that no 
diffusible regulatory molecules influenced the predetermined expression of parental 
genetic information (4). These results could also be explained by control of H-2 gene 
expression that is haplotype specific or by the loss of the chromosomes that contain 
the H-2 genes from the teratocarcinoma parent. We now report the analysis of H-2 
expression  on  somatic  cell  hybrid  clones  derived  from  fusions  of  two  different 
teratocarcinoma cell lines with differentiated mouse cells. We present  evidence for 
two levels of control of H-2 expression. In hybrid clones that resemble ECC, the H-2 
expression is conditional upon differentiation. In those that do not resemble ECC and 
are morphologically differentiated, H-2 gene products are found. Expression of the 
H-2K-  and  H-2D-coded  molecules  in  these  hybrids  appears  to  be  independently 
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controlled. In addition, when H-2 is present on these hybrid cell surfaces, the H-2D 
gene products are always found and the H-2K antigenic specificities may or may not 
be. 
Materials and Methods 
Cell Lines and Culture Conditions.  The pluripotent ECC line PCC4 aza  1 was  derived from 
embryoid bodies of tumor OTT6050, a retransplantable teratocarcinoma originally produced 
by grafting a 6-d-old 129/Sv embryo into the testis of an F1 hybrid (A/He ×  129/Sv) mouse 
(5). The cell line is 8-aza resistant (6, 7). We selected the clone F9 5-bromodeoxyuridine (BrdU) 
7C12, derived from the nullipotent ECC line F9 (8), for its resistance to BrdU. PCC4 aza 1 and 
F9 BrdU  7C12  are grown in Falcon tissue  culture flasks  (Falcon Labware,  Div. of Becton, 
Dickinson & Co., Oxnard, Calif.)  with Dulbecco's modified Eagle's medium (DMEM) supple- 
mented with 15% fetal bovine serum (FBS) (Reheis Chemical Co., Chicago, Ill.) and 15 #g/ml 
of 8-aza or 30 #g/ml of BrdU, respectively.  Both cell lines are derived from  129/Sv mice that 
are of the H-2  ~  haplotype, which is serologically indistinguishable  from the H-2  b haplotype. 
The  three  cell  lines, K129SV  (H-2b),  KC3HSV  (H-2k),  and  KD2SV  (H-2  d)  are  SV40- 
transformed kidney-derived fibroblasts, maintained as described previously (9). The BW 5147 
(H-2 k) cell line is derived from an AKR/J T cell lymphoma adapted to tissue culture (10) and 
is resistant to 8-aza.  BW 5147 cells were maintained in RPMI-1640 (Grand Island Biological 
Co., Grand Island, N. Y.) that contained 10% FBS and 15 #g/ml of 8-aza. The EL-4 cell line, 
H-2  b positive,  Iab negative (11), was grown in DMEM with  10% FBS.  All cell cultures were 
incubated at 37°C in a humidified atmosphere with a constant flow of 5% CO2. 
Cell Hybridization.  Splenocytes were prepared by gentle teasing of freshly  dissected C3H/ 
HeJ spleens. The erythrocytes were lysed by incubation in 4 ml of 0.83% ammonium chloride 
(4 min at 4°C), and the cells were collected after centrifugation through a 2-ml FBS underlay 
(400 g for  10 min). PCC4 aza 1 and F9 BrdU 7C12 cells were harvested with 0.25% trypsin in 
Ca  ++-  and  Mg++-free  Dulbecco's modified phosphate-buffered saline (PBS)  that  contained 
0.9% EDTA. Single-cell suspensions of BW 5147 cells were prepared by vigorous pipetting. 
Spleen cells and PCC4 aza  1 cells were washed once in serum-free DMEM and mixed at a 
ratio of 10:1. F9 BrdU 7C12  (9 ×  106) and BW 5147  (11  ×  106) cells were harvested, washed 
once with serum-free DMEM, and mixed. The pelleted mixture was resuspended in 0.3 ml of 
45% polyethylene glycol 1,000 (J. T. Baker Chemical Co., Phillipsburg, N. J.), incubated for 75 
s in a water bath at 37°C, diluted by the dropwise addition of 5 ml of serum-free DMEM, and 
centrifuged (400 g for 5 min) at room temperature (12). The cells were seeded  in Linbro FB 16- 
24TC tissue culture plates (Linbro Chemical Co.,  Hamden, Conn.) in selection medium that 
consisted of DMEM  supplemented with  15%  FBS,  13.6 /lg/ml hypoxanthine, 0.025  #g/ml 
methotrexate, 3.9 #g/ml thymidine, and 0.225 btg/ml glycine (13). 
Clones were isolated from independent wells that contained a single colony, and subclones 
were obtained by the limiting-dilution  technique. These cloned cell lines were determined to be 
hybrid by their growth in selection medium, chromosomal analysis, and observation of isozyme 
heteropolymers. 
Antibodies.  Anti-H-2 sera were supplied by the Transplantation and Immunology Branch, 
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
Md. Anti-H-2K  b (D-33), derived from (B10.D2  ×  A)F1 anti-B10.A(5R), detects private speci- 
ficity 33 (H-2K  b) along with public specificities  53 and 54, and contains some anti-Ia  b activity. 
Anti-H-2-D  h (D-2), from [B10.A(5R)  ×  LP.RIII]F1 anti-B10, detects private specificity 2 (H- 
2D  b) and public specificity  56. Anti-H-2K  k (D-23),  from (B10 X LP.RIII)F1 anti-B10.A(2R), 
detects  private specificity 23 (H-2Kk),  and may contain anti-Ia  k activity. Anti-H-2D  k (D-32), 
from  [B10.A(2R)  ×  C3H.SW]F1  anti-C3H, detects private specificity 32 (H-2Dk). Anti-H-2D  a 
(D-4), from (B10.AKM ×  129)FI anti-B 10.A detects only the private specificity 4 (H-2Dd). 
Ascites fluid (kindly supplied by Dr. K. Rajewsky, University of Cologne, Cologne, Federal 
Republic of Germany) from mice injected with the B22-249 R1  hybridoma cells (14) was the 
source  of the  monoclonal antibody recognizing the  H-2.2  private specificity (H-2Db).  This 
antibody is of the IgG2a class and was used at a  1:4,000 dilution in indirect antibody-binding 
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Ascites fluid from a  BALB/c mouse,  injected with  11-4.1 hybridoma cells (15)  (obtained 
from Dr. Inga Meichers, Stanford University, Palo Alto, Calif.) was the source of monoclonal 
antibody recognizing a public specificity common to H-2K  k, H-2K  p, H-2K  q, and H-2K  r. This 
antibody is also of the IgG2a class and was used at a  1:1,000  dilution. 
The monoclonal antibody that detects a stage-specific embryonic surface antigen-1 (SSEA- 
1)  expressed on early embryo and  ECC  has been described in detail (16).  The anti-SSEA-1 
reagent  used  was  serum  from  an  ascites-bearing BALB/c  mouse  that  had  been  injected 
intraperitoneally with  106 anti-SSEA-1 antibody-producing hybrid cells mixed with Freund's 
complete adjuvant. The anti-SSEA-1 reagent was used at a dilution of 1:32,000  (~75% of the 
maximal binding on F9 BrdU 7C12 cells). 
Preparation of Cells for  Immunoassays.  Tissue  culture  cells  were  harvested,  counted,  and 
suspended in 0.01  M  Hepes-buffered (Sigma Chemical Co., St. Louis, Mo.) Eagle's minimal 
essential medium (MEM) that contained  10% FBS. Splenic lymphocytes were obtained from 
freshly dissected and  teased spleens after lysis of erythrocytes and  centrifugation through  a 
layer of FicolI-Hypaque (1.077 g/ml) (LymphoPrep, Nyegaard and Co., Oslo, Norway). Linbro 
round-bottom microtiter plates (IS-RB-96, Linbro Chemical Co.) were used for all incubations 
of target cells with antisera. 
Immunoassays.  The  RIA and  the preparation of 12SI-rabbit  anti-mouse IgM and  IgG are 
described elsewhere (17). Results are reported as the average counts per minute from triplicate 
samples minus the average counts per minute bound to cells incubated with a corresponding 
dilution of control myeloma-induced ascites fluid. 
Absorption of conventional H°2 antisera was performed by incubating increasing numbers 
of hybrid or control cells (0.5 ×  106, 2 ×  106, and 8 ×  106) in 60 #1 of antiserum at a dilution 
sufficient to lyse 60-85% of target splenic lymphocytes. After incubation at 4°C for 60 min on 
a  shaker, the cell suspensions were centrifuged and  the su~ernates assayed. For cytotoxicity 
tests, 9 #1 of target cell suspension that  contained 3  ×  10  cells was added to  the  50 #l of 
absorbed serum, incubated at 36°C for 30 min on a shaker, and washed once with PBS that 
contained 2.5% FBS. The target cell pellets were then resuspended in 50#1 of rabbit complement 
(diluted 1:10 with Hepes-MEM) and incubated for 30 min at 36°C on a shaker. The percentage 
of dead  cells was  determined by erythrosin B  dye exclusion. C57BL/6Jband  129/J  splenic 
lymphocytes or EL-4 cells were used as targets for anti-H-2K  and  -2D  sera; AKR/J and 
C3H/HeJ splenic lymphocytes were used as targets for anti-H-2K  k and -2D  k sera; and BALB/ 
c  ICR  (Institute for Cancer Research, Fox Chase,  Pa.)  splenic lymphocytes for anti-H-2D  d 
serum. Absorption of antisera was always performed with all three cell concentrations; however, 
for ease of comparison, data are sometimes presented as the percent reduction of cytotoxicity 
on target lymphocytes after absorption with 2 ×  106 cells only. 
Results 
Two series of hybrid clones were investigated: PCC4 aza  1 fused with C3H  spleen 
cells (the 477 series) and F9 BrdU 7C12 fused with BW 5147  (the 978 series). The 477 
hybrids resemble  ECC  morphologically, and  both  ECC  and  five  independent  477 
hybrids bind antibody to the stem cell-specific surface marker SSEA-1  (Table I). In 
addition, clones of the 477 hybrids do not express the H-2 antigens of the H-2 b or H- 
2 k  haplotype.  Fig.  1 a  gives  an  example  in  which  anti-H-2D  k  serum  failed  to  be 
absorbed with increasing numbers of cells from 477-1 clones I, DD, and GG. Identical 
data  were  obtained  with  antisera  specific  for  the  H-2D  b,  -2K  b,  or  -2K  k  molecules 
(Table II). 
If these clones were maintained without subcuhivation,  but with medium change 
every 2nd d  for 2-3 wk (aged cultures), differentiated cells appeared and became the 
dominant  subpopulation in the cultures.  Data  from  two  representative experiments 
concerning expression of H-2 antigens on aged cultures are presented in Fig.  1 b  and 
Table II. The D4 antiserum is included for control purposes. Cells from the aged 477- 
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TABLE  I 
Expression  of SSEA-I on Hybrid and Control Cells 
PCC4 aza 1 × C3H spleen cells  F9 BrdU 7C12 ×  BW 5147 
cpm *  cpm * 
477-1 B  10,100  978-1-5  0 
477-1 P  7,900  978-1-6  0 
477-1 I  11,400  978-2-1  0 
477-1 DD  12,800  F9 BrdU 7C12  8,700 
477-1 GG  12,800  BW 5147  0 
PCC4 aza 1  10,800  K129SV  0 
* Counts  per minute bound  to 5 X  105 cells after incubation with 50/.d ~- 
SSEA- 1 (1:32,000) followed by 50 ~112SI-rabbit anti-mouse IgM (heavy-chain 
specific).  The  values  represent  the  average counts  per  minute  bound  to 
triplicate  cell  samples  minus  the  counts  per  minute  bound  to  triplicate 
samples  of each cell  (200-800  cpm)  when  incubated  with  1:32,000 ascites 
fluid from mice bearing the P3-X-63-Ag8  myeloma (12). 
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FIe.  1.  Quantitative absorptions ofanti-H-2D  k (D-32) with 477 hybrid cells (a) and with aged 477 
hybrid  (b)  cells. After absorption with KC3HSV  (O), K129/SV  (A), PCC4 aza  1 ([5]), 477-1  I or 
477-1 I aged (O), 477-1 DD or 477-1 DD aged (A), or 477-1 GG or 477-1 GG aged (1), the residual 
cytotoxic  activity of anti-H-2D  k (D-32) was tested  by complement-mediated cytotoxicity on spleen 
lymphocytes  from AKR/J mice. u, unabsorbed antiserum; c', complement control. 
2K  b,  -2D  b,  -2K  k,  and  -2D  k  molecules.  Cells  from  the  aged  clone  477-1  DD  absorb 
considerable activity from anti-H-2D b and  H-2D k sera, whereas,  the specific cytotox- 
icity of the  D33  (H-2K  b)  and  D23  (H-2K k)  sera  is somewhat  reduced.  Cells of aged 
clone 477-1  I  do not express any  H-2 antigenic specificities; the partial  absorption  of 
the anti-H-2D b serum  proved insignificant  in  repeated  experiments. 
It was  possible  that  the presence  of antibodies  against  Ia determinants  in  the  two 
antisera  directed  against  the  H-2K  specificities  could  alter  the  absorption  results 
obtained. To exclude this possibility, we tested the anti-H-2K b serum after absorption 
both on H-2K b- and Ia-expressing C57BL/6J  spleen lymphocytes, and on Ia-negative, 
H-2Kb-positive  EL-4  cells.  Activity  of the  absorbed  antiserum  was  reduced  to  the 
same extent on both target cells. A  monoclonal antibody to a  public specificity present 
on  the  product  of the  H-2K k  allele,  and  not  of the  H-2K b  allele,  was  also  used  to R.  GMUR,  D.  SOLTER,  AND  B.  B.  KNOWLES 
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H-2K  b  H.2D  b  H.2K  k  H-2D  k  H-2D  d 
(D-33)  (D-Z)  (D-23)  (D-32)  (D-4) 
%, 
477-1 B  22.3  6.2  6.8  17.1  ND 
477-1 P  5.3  20.3  3.5  14.9  ND 
477-1 I  19.5  16.6  17.2  15.2  ND 
477-1 I aged  12.3  38.3  24.3  20.5  22,1 
477-1 DD  11.3  17.2  10.3  18.6  ND 
477-1 DD aged  30.0  69.9  26.2  54.6  1.8 
477-1 GG  23.1  37.5  12.0  19.5  ND 
477-1 GG aged  83.4  78.9  85.9  66.8  3.4 
PCC4 aza 1  10.0  9.4  7.1  6.5  ND 
C3H splenocytes  7.0  0  94.8  91.8  ND 
129 splenocytes  96.1  93,7  3.5  4.5  ND 
KC3HSV  3.9  1,7  70.9  59.1  3,7 
K129SV  80.6  79.1  7.1  4.5  ND 
KD2SV  ND  ND  ND  ND  84.4 
* Genotypes  and private specificities  that are recognized  by National Institutes 
of Health typing sera. 
* Percent reduction of cytotoxicity of a given  anti-H-2 serum after absorption 
with 2 X 10  s cells. Percent reduction -- [ci(u) -  ci(t)]/[ci(u)] X 100, where 
ci(u) is the cytotoxic index of unabsorbed serum and ci(t) is the cytotoxic 
index of the serum absorbed with test cells. Cytotoxic index (ci) = (T -  C)/ 
(100 -  C) X 100, where T is percentage of cells killed by the serum tested, 
and C is the percentage killed by complement only. Target cells are C57BL/ 
6J (H-2K  b and H-2Db), AKR/J (H-2K  k and H-2Dk), or BALB/c ICR (H- 
2K  d and H-2D  d) splenic lymphocytes. ND, not determined. 
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detect the presence of H-2K  k molecules. This antibody recognizes a different specificity 
from  that  detected  with  the  conventional serum  and  excludes  the  possibility of 
contaminant antibodies to Ia  k determinants. Analysis of the reactivity of this mono- 
elonal antibody on the  hybrid clones  (Table III)  confirms the  results obtained by 
absorption. The 477-1  GG aged clone reacts with this monoclonal reagent, whereas 
the two other aged clones do not. 
Hybrids of the 978 series (F9 BrdU ×  BW 5147) are morphologically different from 
each of the parental cells. These hybrids are large, substrate-attached fibroblastic cells 
and do not express either the SSEA-1 surface marker of the teratocarcinoma parent 
(Table I)  or the Thy-l.1  marker present on  BW 5147  cells  (results not shown).  In 
contrast to the 477-1 hybrid clones, H-2 antigens are expressed on each of the three 
hybrid clones tested.  To  control the  H-2  assays,  two  SV40-transformed, substrate- 
attached  cell  lines  (K129SV  and  KC3HSV)  derived  from  mice  of the  same  H-2 
haplotype as the parental cells of the hybrid were used, as well as AKR/J  and 129/J 
lymphocytes and both  parental cell  lines  (F9  BrdU  7C12  and  BW  5147).  Splenic 
lymphocytes absorb slightly more of the specific reactivity from specific test sera than 
the SV40-transformed control cell lines, whereas BW 5147 absorbs considerably less. 
Results from the F9 BrdU  7C12 cell line parallel the negative control cells. Cells of 
the 978-1-6 hybrid clone express H-2K  b, -2D  b, -2K  k, and -2D  k antigenic specificities; 1354  H-2  EXPRESSION  IN TERATOCARCINOMA  SOMATIC  CELL  HYBRIDS 
TABLr  III 
H-2 Expression on Hybrid and Control Cells Detected by Monoclonal Antibodies 
PCC4 aza 1 × C3H spleen cells  F9 BrdU 7C12 × BW 5147 
Reagent  Reagent 
Cells  Cells  11-4.1  11-4.1  B22-249R  1 
(anti-H-2K  k)  (anti-H-2K  k)  (anti-H-2D  b) 
cpo'/*  cp;92 * 
477-1 B  0  978-1-5  D8  1,400  6,120 
477-1 P  0  978-1-5  Dll  420  5,930 
477-1 I  0  978-1-5  H9  620  5,670 
477-1 I aged  0  978-1-5  H12  1,400  3,390 
477-1 DD  0  978-1-6  2B12  166  1,900 
978-2-1 2B6  150  570 
477-1 DD aged  150  978-2-1  2F8  260  2,240 
477-1 GG  0  F9 BrdU 7C12  240  124 
477-1 GG aged  1,200  BW 5147  2,000  170 
PCC4 aza 1  0  KC3HSV  4,500  60 
KC3HSV  4,400  KI29SV  230  5,320 
K 129SV  0 
* Counts per minute bound to 5 ×  105 ceils after incubation with 50/.d ll-4.1  (1: 
1,000) or B22-249R1 (1:4,000) followed by 50 #112~I-rabbit  anti-mouse IgG (heavy- 
and light-chain specific). The values represent the average counts per minute bound 
to triplicate cell samples minus the counts per minute bound to triplicate samples 
of each cell (200-1,000 cpm) when incubated with 1:1,000 ascites fluid from mice 
bearing the P3-X-63-Ag8  myeloma (12). 
cells from the 978-2-1 clone express H-2D  b, -2K  k, and -2Dk; and cells from the 978-1- 
5  clone express  only H-2D  b and  -2D  k specificities  (Fig.  2).  The  same  results were 
repeatedly obtained with different passages of these hybrid clones. 
Each  of the  original hybrid clones were  subcloned, and  the  subclones were  also 
repeatedly analyzed for H-2 expression. Results from a  representative experiment are 
shown in Table IV. For comparative purposes results taken from Fig. 2 are also shown 
on this table. By comparing the calculated percent reduction of cytotoxicity (Table 
IV)  with  the  absorption curves  (Fig.  2)  one can  see  that,  e.g.,  20.2%  reduction of 
cytotoxicity of the  D-33  sera  after  absorption with  clone 978-2-1  is  not  significant 
because four times more cells absorb the same amount of activity. This same analysis 
was used to interpret all of the data in Table IV. The hybrid 978-1-5 is H-2D  b and 
-2D  k positive, and its subclones 978-1-5 D8 and H 12 express specificities of all four of 
the H-2 molecules. Subclones (978-1-5 D1 1 and H9)  express only the specificities of 
the H-2D  b and -2D  k molecules. Subclone 978-1-6 2B12  (derived from a  clone that is 
H-2K  b,  -2D  b,  -2K  k,  and  -2D  k  positive)  expresses  H-2K  b  and  -2D  b,  but  not  the 
specificities  of  the  H-2  k,  haplotype.  This  result  is  compatible  with  loss  of  both 
chromosomes  17  derived from  the  BW  5147  parent.  Clone 978-2-1  is  H-2D  b, -2K  k, 
and -2D  k positive.  Its subclone 978-2-1  2B6 expresses  none of the  H-2 specificities, 
whereas subclone 978-2-1 2F8 expresses H-2D  b and -2D  k only. 
Data from the absorption of the D-23 sera  (anti-H-2K  k)  were correlated with the 
reactivity of the  monoclonal antibody to  a  public specificity of the  H-2K  k  allele. 
Subclones of  the  978  hybrids,  which  were  clearly  H-2K  k  negative  in  absorption 
experiments (978-2-1  2B6 and 978-2-1  2F8), do  not  bind this monoclonal antibody _,-5 
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FIe.  2.  Quantitative  absorption  of (a)  anti-H-2D b (D-2),  (b) anti-H-2D k (D-32),  (c)  anti-H-2K b 
(D-33), and (d) anti-H-2K k (D-23) with 978 hybrid clones and control cells. After absorption  with 
KC3HSV (A), K129SV (O), 978-1-5 (O), 978-1-6 (&), or 978-2-1  (I),  the residual cytotoxic activity 
of  the  antisera  was  tested  by  complement-mediated  cytotoxicity  on  splenic  lymphocytes  from 
C57BL/6J (D-2 and D-33) or AKR (D-32 and D-23) mice. u, unabsorbed antiserum; e', complement 
control. 
(Table  III).  Subclones  that  absorbed  the reactivity  from  the  D-23  serum  bind  the 
monoclonal reagent.  Subclones 978-1-5 D11  and H9, which were judged negative in 
absorption analysis, do bind a  small  amount of this monoclonal reagent, and, thus, 
the possibility exists that  H-2K  k is weakly expressed  on all or some of these hybrid 
cells. The reactivity in RIA of the subclones with monoclonal antibody, recognizing 
H-2.2 (private specificity of H-2D  b) is in complete agreement with the data from the 
absorption experiments. 
Discussion 
The 477 hybrids (PCC4 X C3H spleen) reported here resemble ECC both morpho- 
logically and in their expression of cell surface antigens. When teratocarcinoma stem 
cells differentiate in vitro, they no longer express SSEA-1  (18), and the differentiated 
cells express  H-2 molecules  (19). Although the 477 hybrids are SSEA-1  positive and 
H-2  negative,  they  differentiate  and  express  H-2  antigens  after  aging  in  culture. 
Extinction of the expression of the H-2 antigens of the nonteratocarcinoma parental 
cell is at variance with previous reports (3, 4); our results indicate that H-2 expression 1356  H-2  EXPRESSION  IN TERATOCARCINOMA  SOMATIC CELL  HYBRIDS 
TABLE IV 
H-2 Expression  on F9  X  BW 5147 Hybrid Clones, Subclones, and Control 
Cells Detected by Absorption Analysis 
Cells 
Antisera* 
H-2K  b  H-2D  b  tt-2K  k  H-2D  k 
(D-33)  (D-2)  (D-23)  (D-32) 
%§ 
978-1-5~  22.9  87.2  27.7  82.9 
978-1-5 D8  89.9  90.5  38.9  41.3 
978-1-5 Dll  10.1  91.7  24.4  43.0 
978-1-5 H9  10.1  84.5  25.0  37.6 
978-1-5 H12  31.4  67.9  30.1  40.5 
978-1-6:]:  42.3  98.4  80.6  79.3 
978-1-6 2B 12  44.6  44.0  20.7  15.3 
978-2-1~  20.2  94.1  66.3  88.4 
978-2-1 2B6  7.1  0  0  0 
978-2-1 2F8  0.8  63.1  0  26.0 
F9 BrdU 7C12  3.5  0  11.0  4.1 
BW 5147  0  2.3  28.4  25.5 
K 129SV~:  92.3  86.6  0  4.1 
KC3HSV~:  0  0  68.8  48.9 
EL-4  100  95.2  13.4  0 
* Genotypes and private specificities that are recognized by NIH typing sera. 
Results from Fig. 2. 
§ Percent reduction of cytotoxicity of anti-H-2 serum after absorption with 2 
X 106 cells is calculated as described in Table II. Target cells are C57BL/6J 
(H-2K  b and H-2D  b) or AKR/J (H-2 K  k and H-2D  k) splenic lymphocytes. 
in hybrids of stem cell morphology is regulated as in ECC and rule out cis control of 
H-2 expression. Moreover, because H-2 antigenic specificities of both parents appear 
after aging in culture, loss of the chromosomes that bear the structural genes for H-2 
is impossible. In previous reports  (3, 4), the authors examined the expression of only 
one of the H-2 gene products from each parental cell (H-2K  k and -2K  b or H-2K  k and 
-2D  b,  respectively)  ~tnd  did  not  mention  whether  the  cultures  contained  mixed 
populations of differentiated and stem cells.  Because we  show  that  H-2K and -2D 
gene expression are independently controlled and dependent upon in vitro differen- 
tiation, our data and those previously reported are not necessarily at variance, though 
our conclusions differ. 
The 978 hybrids (F9 X BW 5147) are morphologically different from ECC and the 
477  hybrids.  The  978  hybrid  clones  do  not  express  the  teratocarcinoma-specific 
antigenic determinant SSEA-1  nor the thymoma characteristic Thy-1.1 and they do 
express  H-2.  Both  the  in vitro characteristics of the  978  hybrids and  the  fact  that 
tumors derived from injection of 978 hybrid cells are not teratocarcinoma (data not 
shown) contrast these hybrid clones with the 477 hybrids and ECC. 
Analysis of H-2 expression in these two sets of hybrids suggests two levels of control. 
If the hybrid cells are indistinguishable  from ECC, the H-2 molecules of both parents 
are  not expressed.  We feel  that  positive suppression by regulatory gene products of 
the teratocarcinoma parent is the most probable mechanism. A second level of control 
is also suggested for we find that  the H-2K and -2D gene products of both parental R. GMOR, D. SOLTER, AND B. B. KNOWLES  1357 
cells can be independently expressed. Furthermore, if H-2 antigenic determinants are 
present on the hybrid cell surface, the H-2D gene products are always found and the 
H-2K genes may or may not be expressed. The absence of the H-2K gene product, 
consequently, can not be explained by the loss of the chromosomes that contain the 
structural genes for H-2 or fl2-microglobulin. 
Any attempts  to postulate a  mechanism  for the control of H-2 expression must 
include the concept that there is no simple on/off control of all of the H-2 genes. The 
parental cell of the 978 hybrids, BW 5147, is derived from an AKR thymoma. Both 
the H-2K  k and -2D  k gene products are only weakly expressed on BW 5147 and it may 
be that the differentiated expression of H-2K in the hybrid cells is the consequence of 
aberrant  gene regulation in this parental cell line.  However, the 477  hybrids show 
independent  expression  of the  H-2D  gene  products,  and  some  clones  of the  978 
hybrids do strongly express the H-2K antigenic determinants. Preferential extinction 
of the H-2K gene product  may simply be peculiar to the  H-2  k haplotype because 
differential  H-2K  and  -2D  gene  expression  has  been  primarily  observed  in  this 
haplotype (20). 2 We believe that this regulatory control is H-2K gene specific and not 
allele specific because the data from these hybrid cells imply joint control of the H- 
2K  k and -2K  b gene products. We can postulate mutations that affect the H-2K and 
not the H-2D genes. The H-2K locus appears  to be hypermutable in vivo because 
most  of the mutations  that  affect H-2 genes were  found in  the  H-2K region  (21). 
Additionally, cell lines derived from AKR thymomas are reported to express products 
of the  H-2D  k gene, but  not  those  of the  H-2K  k gene  (20).  However, attempts  to 
immunoselect for the absence of H-2 expression in cell cultures has resulted in isolation 
of cells that have lost either H-2K or H-2D expression (22). We feel that mutation of 
the  H-2K  structural  genes  is  highly  unlikely  because  three  of six  independently 
derived clones from two different parental cell lines would have been affected by such 
a  mutation. In two of these clones the H-2K products from both parental cells are 
affected. Moreover, two subclones of the 978-1-5 clone express the H-2K  k gene product 
that  is  not  present  on  the  original  clone.  Another  possible  explanation  for  this 
differential expression is the loss  of some of the chromosomes that  contain  the fl2- 
microglobulin structural genes; gene dosage would thus result in a limiting supply of 
/~2-microglobulin molecules. This mechanism would imply a  preferential affinity of 
the H-2D gene products for fl2-microglobulin. The expression of the H-2K  k specificities 
in the 978-1-5 subclone D8, once again could argue against this point. 
A more likely explanation of our results is that regulatory genes exist with products 
specific for either the H-2K or the H-2D loci. These regulatory products would allow 
independent expression of the H-2K and -2D genes. We believe that the H-2D gene 
is expressed first during differentiation with subsequent activation of the H-2K gene. 
The H-2D-positive, H-2K-negative hybrids reported here would then represent inter- 
mediary steps in the differentiation process. This hypothesis is supported by the recent 
observation that  populations of cells in  the  thymus  are  H-2K negative and  H-2D 
positive, whereas peripheral T  cells express products of both  H-2K and  -2D.  2 The 
hybrid clones and subclones described here, with their differing expression of the H- 
2 Scollay, R., S. Jacobs, L. Jerabek, E. Butcher, and I. Weissman. T-cell maturation: thymocytes  and 
thymus migrant subpopulations defined with monoclonal  antibodies to MHC-region antigens.J. Immunol. 
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2 gene products, will prove useful in the investigation of the mechanisms that control 
the regulation of H-2 expression. 
Summary 
Cells of two teratocarcinoma stem cell lines  (PCC4 azaguanine  [aza]  1 and F9 5- 
bromodeoxyuridine  [BrdU])  were fused with  normal  mouse spleen  cells and  mouse 
thymoma-derived cells  (BW  5147),  respectively.  Hybrid clones  were  tested  for  the 
expression of molecules coded by the H-2K and -2D genes both by absorption analysis 
of conventional  H-2 sera and by indirect  antibody-binding radioimmunoassay with 
monoclonal antibodies.  Somatic cell  hybrids  between  PCC4  aza  1 and  spleen  cells 
morphologically resemble teratocarcinoma stem cells and do not express H-2 antigens. 
However, after differentiation in vitro, one of these hybrid clones expresses the H-2K 
and -2D gene products of both parental cell lines, one clone expresses H-2D- but not 
H-2K-coded antigenic  determinants,  and one clone remains  H-2 negative.  Somatic 
cell hybrids between F9 BrdU and BW 5147 resemble fibroblasts. Analysis of a series 
of hybrid clones revealed some clones that express both the H-2K- and H-2D-coded 
antigenic specificities of both parental alleles, some that express H-2D gene products 
strongly and the H-2K gene products very weakly, and some that express H-2D- but 
not H-2K-coded molecules. These results imply independent  regulation of expression 
of the  H-2K and  -2D  genes.  The  H-2D gene  products  appear to  be preferentially 
expressed if the hybrid cells are capable of expressing H-2. The results suggest complex 
regulatory mechanisms that are H-2K and H-2D specific. 
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